NovoSeven Partial Change Approval
Eptacog alfa (activated) (genetical recombination)
Approval Information
Brand NameNovoSeven
Partial Change Approval
Generic NameEptacog alfa (activated) (genetical recombination)
ApprovedSeptember 2024
TypeInitial Approval
Review Reports
Want structured data, translation summaries & alerts?
PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.
Join the WaitlistSource: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.